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many are available.
Methods: Using a crossover design, 20 dyads tested two similar commercial GPS watches (products
A and B) at home for 4 weeks each. Usability, product functions, design features and product satis-
faction at home and the clinic were investigated. Caregiver burden and quality of life assessed clinical
effectiveness.
Results: The final 17 dyads rated the usability, telephone function, overall design features, font,
buttons, and battery life of B significantly better than A. PwDs rated the overall design features
and buttons of A significantly better than CGs. Product satisfaction with both products was signifi-
cantly lower at home. Clinical effectiveness was not found.
Discussion: User experience can be improved by optimizing specific product details. This might
translate to clinical effectiveness. Social desirability bias may explain different product satisfaction
ratings.
 2018 The Authors. Published by Elsevier Inc. on behalf of the Alzheimer’s Association. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
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Assistive technologies intended to aid persons with de-
mentia (PwDs) and their primary caregivers (CGs) can be
seen as promising, potentially cost-effective tools that could
help optimize the amount of care provided in informal care
settings [1,2]. “Tracking” or locating systems are specifict: None to report.
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commons.org/licenses/by-nc-nd/4.0/).assistive technologies that enable the location of PwDs
through a global positioning system (GPS) technology.
Accordingly, GPS devices aim to promote the safety of
PwDs who exhibit wandering behaviors [3,4]. Therefore,
these products can also reduce the stress and burden
experienced by PwDs and CGs that is typically associated
with wandering behaviors [5,6].
To date, studies on prototype and commercial GPS de-
vices in dementia care have used different product types
with similar functions and design features. Typically, prod-
ucts are small (e.g., pager sized or watch sized), discrete
or nonvisible (e.g., worn around the waist, neck, wrist, orimer’s Association. This is an open access article under the CC BY-NC-ND
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functions (e.g., location, telephone, geofencing, alarm, fall
detection, and speed alert), no buttons (i.e., passive systems)
or one to three buttons (i.e., active systems), and are light-
weight [5–11]. These functions and features are in line
with most expert recommendations [7,12].
However, research has also shown that assistive technol-
ogies for dementia care lack clear-cut quality standards
regarding their design. Moreover, these technologies are
rarely developed using techniques of user-centered design
[13,14]. It is therefore likely that most products exhibit a
suboptimal design, which impedes technology acceptance
and long-term use [7,13]. This may partly explain why
commercial GPS devices for dementia are rarely used
outside clinical research settings [7,10,15], although many
are commercially available [14,16]. Furthermore, most
studies on GPS devices focus on feasibility, acceptability,
and usability [5–10,17,18] without providing a more
holistic understanding of end users’ experience with such
devices. In addition, it is unclear whether the use of such
products results in clinical effectiveness [14,19,20]. As it
stands, findings pertaining to the clinical effectiveness of
assistive technologies are shockingly sparse [13,21,22].
For GPS devices, it is not clear whether they provide
measurable aid in home dementia care beyond being
accepted and feasible.
For these reasons, this study is based on the construct of
user experience (UX), which is typically defined as “a per-
son’s perceptions and responses that result from the use or
anticipated use of a product, system or service” [23]. In
other words, it is a multidimensional construct that in-
cludes affective, cognitive, and behavioral dimensions
that users exhibit before, during, and after product use
[24,25]. The theoretical background of UX overlaps
with key aspects of the technology acceptance model
[26], as a recent review analyzed [27]. In short, this model
states that perceived ease of use and usefulness of a prod-
uct, as well as external factors (e.g., technological affin-
ity) contribute to actual acceptance and use. In contrast,
UX focuses more on specific product characteristics and
their associations with outcomes, including satisfaction
or acceptance, which are moderated by specific usage sit-
uations [28].
Therefore, the central aim of this study was to perform an
in-depth comparison of the UX of PwDs and their informal
CGs with two similar commercial GPS watches in home de-
mentia care. To date, only three studies have compared more
than one commercial GPS device, yet the product types
differed [5,11,18]. Of these studies, one did not collect
data from PwDs [11], one did not focus on UX [5], and
the other focused on acceptability without describing the de-
vices used [18]. A direct comparison of GPS watches is
particularly warranted given that it has been recommended
that products take the form of familiar, everyday objects
(e.g., watch) to help ensure their adoption [7,10].
Furthermore, comparing commercial GPS products couldprovide additional information on their possible
effectiveness [14] and on functions and features that lead
to a more favorable UX. In addition, we examined whether
product satisfaction differs when reported at home versus a
clinical setting. One could hypothesize that PwDs and CGs
report a more positive product satisfaction in clinical settings
based on a social desirability bias [29,30]. A second aim was
to examine whether product use would result in clinical
effectiveness for PwDs and CGs.2. Methods
2.1. Sample
Twenty dyads (n5 20 PwDs, n5 20 CGs) were recruited
following a convenience sampling technique from memory
clinic patients in 2016. PwDs who could move about outside
the home were included. Years since diagnosis and a Mini-
Mental State Examination score assessed up to 1 month
before baseline were available for all PwDs. All participants
provided their written informed consent for participation in
this UX study.
2.2. Materials
Two similar commercial GPS watches marketed for peo-
ple with orientation impairments (hereafter products A and
B) were selected (see Table 1). These were the only two
GPS watches on the German market with a location and tele-
phone function. In combination with products A and B CGs
received a study-specific smartphone to prevent bias with
two native Android applications preinstalled to be able to
locate PwDs. By pressing one defined button of product A
or the button of product B, a call is sent out to the smartphone
and PwDs could accept an incoming call by pressing this
button. With both smartphone applications, CGs could
view the last recognized position of product A or positions
of product B on an online map. To support product learning,
we developed a 60-minute technological training session
based on dementia communication guidelines [31,32].
This included hands-on exercises by having PwD practice
calling and accepting a call from CG, and CG calling and
locating PwD on a map.
2.3. Study design
Products A and B were compared using a 2 ! 2 cross-
over design (sequences ABjBA, two study periods, four
assessment points). Each product was tested at home for
4 weeks. The first study period lasted from baseline at
T1 to T2.1, and the second study period lasted from T2.2
to T3.
2.3.1. First study period
At T1, standard demographic data were measured.
Also, CGs and PwDs were independently asked to report
on a history of wandering events. Then, four secondary
Table 1
Product description of GPS watches for PwDs
A B
Product name HIMATIC GPS Uhr Alpha [HIMATIC GPS Alpha watch] ReSOS-2—Die Notfalluhr [ReSOS-2–the emergency watch]
Product picture
Size 45.5 mm! 64.5 mm! 17.5 mm 43.0 mm! 43.0 mm! 19.0 mm
Weight 70 g 66 g
Main colors Black and blue Black and red
Buttons Five (Ø: 0.5 mm) One (1.8 mm! 0.5 mm)
Band type Silicone strap Silicone strap
Battery Li-ion (3.7 V, 500 mAh) Li-ion (850 mAh)
Charging method DC 5 V USB charger cable Charging station with USB cable
Software/application Native Android App: HIMATIC GPS Uhr Alpha Native Android and iOS App: ReSOS-2
Website https://himaticmobile.de/personenortung.html http://notfall-uhr.de/
Abbreviations: A, product A; B, product B; GPS, global positioning system; PwDs, persons with dementia; USB, Universal Serial Bus.
NOTE. Size noted as width by length by depth; websites last accessed on August 23, 2018; both watches have a SIM card that allows for two-way commu-
nication and GPS connection.
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burden (Zarit Burden Interview, range 0–48) [33], quality
of life of PwDs and CGs (European Health Interview Sur-
veys-quality of life, range 0–48) [34], orientation impair-
ments, and subjective burden of getting lost (self-
developed six-point Likert scales ranging from 0 5 no
impairments/not at all worried to 5 5 very impaired/
very worried, with CGs appraising PwDs). Higher scores
represent more negative endpoints, except for the
European Health Interview Surveys-quality of life. The
covariate technological affinity was assessed for PwDs
and CGs with the technological affinity scale for
electronic products (TA-EG, range 19–95) [35]. Dyads
then randomly received their first product and completed
the technological training session. The primary outcome
measure usability was then assessed with the Interna-
tional Standardization Organisation Norm (ISONORM)
9241/10 scale (range 0–210) [36,37]. This scale
relies on principles of the International Standardization
Organisation [38] and is recommended for UX studies
[39]. The scale measures seven usability domains,
including suitability for the task, self-descriptiveness,
controllability, conformity with user expectations, error
tolerance, suitability for individualization, and suitability
for learning. For the TA-EG and ISONORM 9241/10
scales, higher scores represent more positive endpoints.
At T2.1, dyads returned to the clinic and first performed
the same tasks as at T1 during the technological training ses-
sion as a way to control product learning, followed by a re-
assessment of usability with the ISONORM 9241/10 scale.Thereafter, dyad members rated two further primary
outcome measures, namely the main product functions
(i.e., telephone and location) and design features (i.e., color,
font, size, weight, buttons, and battery life) on five-point
Likert scales ranging from 0 5 not at all good to 4 5 very
good. Font ratings assessed the font’s typeface, size, and co-
lor, and ratings of buttons measured amount, size, sound,
haptic feedback, and color. Then, dyads jointly rated their
overall product satisfaction using the same five-point Likert
scale. In addition, the covariate subjective frequency of use
of the location function was assessed by CGs on a five-point
Likert scale ranging from 05 not at all to 45 very often. All
custom items are displayed in Supplementary Table 1. Also,
secondary outcome measures and the TA-EG were readmi-
nistered. Finally, participants were asked whether any wan-
dering events and technical difficulties with the product had
occurred.
2.3.2. Second study period
T2.2 directly followed T2.1. Here, dyads received their
second product and completed the technological training
session, followed by filling out the ISONORM 9241/10
scale. At T3, dyad members’ UX with the second product
was assessed following the same methodological procedure
as at T2.1.
2.3.3. Home assessments
At the end of each week, dyads jointly rated their overall
weekly product satisfaction with product A or B at home
with the same question as at the clinic.
Table 2
Participant characteristics at baseline (T1)
Characteristics
PwDs
(n 5 17)
CGs
(n 5 17)
Age, mean 6 SD [range] 71.7 6 6.9 [56–80] 67.7 6 8.0 [51–77]
Gender ratio (% female) 8/9 (53) 9/8 (47)
Education
High school, n (%) 7 (41) 7 (41)
College, n (%) 2 (12) 1 (6)
University, n (%) 8 (47) 9 (53)
MMSE score,
mean 6 SD [range]
18.2 6 4.3 [12–25] —
Mild dementia
(20–25), n (%)
8 (47) —
Moderate dementia 9 (53) —
H. Megges et al. / Alzheimer’s & Dementia: Translational Research & Clinical Interventions 4 (2018) 636-644 6392.4. Statistical analysis
Data were analyzed using Statistical Package for the
Social Sciences Statistics 24. Because of the nonindepen-
dence between PwDs and CGs within a dyad [40], PwDs
and CGs data were analyzed with paired samples t tests for
primary and secondary outcome measures. Independent
samples t tests between products were additionally per-
formed for primary outcome measures. Furthermore, sec-
ondary outcome measures and covariates were analyzed
with Spearman’s rank-order correlations and one-way
repeated measures analysis of variances. Potential order
effects between sequences AB and BA were examined
with independent samples t tests.(12–19), n (%)
Years since diagnosis
.1, n (%) 1 (6) —
1–2, n (%) 5 (29) —
2–3, n (%) 4 (24) —
3–4, n (%) 2 (12) —
.5, n (%) 5 (29) —
History of wandering
events
None, n (%) 14 (82) 7 (41)
1–3 times, n (%) 3 (18) 8 (47)
4–6 times, n (%) 0 2 (12)
.7 times, n (%) 0 0
TA-EG (19–95) 71.2 6 7.3 [58–85] 74.1 6 6.1 [63–83]
Abbreviations: CGs, caregivers; MMSE, Mini-Mental State Examina-
tion; PwDs, persons with dementia; SD, standard deviation; TA-EG, techno-
logical affinity scale for electronic products.
NOTE. Percentages rounded to the nearest whole number.3. Results
3.1. Participant characteristics
Baseline data were first inspected for outliers, and one
dyad with a PwD Mini-Mental State Examination score
more than 2 SDs (standard deviations) below the mean
was excluded [41]. Two dyads dropped out at T2.1 (dropout
rate 10%) stating product dissatisfaction because of tech-
nical difficulties, with no other significant differences
compared with nondropouts, and both dyads received
different products. In the final sample of 17 dyads (n 5 17
PwDs, n 5 17 CGs), seven received product A and 10
received product B at T1 and vice versa at T2.2. Ten CGs
and three PwDs reported a history of wandering events.
All participant characteristics are displayed in Table 2.Table 3
ISONORM 9241/10 usability ratings over the course of the study
Sequence
Study period 1 Study period 2
T1 T2.1 T2.2 T3
AB (n 5 7 dyads)*
PwDs 126 6 37.3y 116 6 58.8 170 6 15.3 168 6 32.9
CGs 165 6 36.2y 147 6 20.9 179 6 17.7 155 6 39.8
BA (n 5 10 dyads)*
PwDs 170 6 28.2 153 6 48.8 117 6 49.6 111 6 67.0
CGs 171 6 28.8 176 6 21.5 128 6 36.7 123 6 56.7
Abbreviations: A, product A; B, product B; CGs, caregivers; PwDs, per-
sons with dementia; ISONORM, International Standardization Organisation
Norm; SD, standard deviation.
NOTE. Continuous variables are displayed as mean value 6 SD.
*Independent samples t tests for dyads: B rated better than A at all time
points, P value ,.05.
yPaired samples t tests for within-dyad effects: PwDs rated Aworse than
CGs, P value ,.01.3.2. Primary outcome measures
Results of the ISONORM9241/10 usability scale for both
products were fair to good and are presented in Table 3 and
Supplementary Fig. 1. Independent samples t tests showed
that dyads rated product B better than A at all assessments.
At T1, t(32) 5 22.11, P , .05 (MA 5 146, SD 5 40.7,
MB 5 171, SD 5 27.7); at T2.1, t(32) 5 22.29, P , .05
(MA 5 131, SD 5 45.5, MB 5 164, SD 5 38.6); at T2.2,
t(32) 5 24.32, P , .001 (MA 5 123, SD 5 42.9,
MB 5 175, SD 5 16.6); and at T3, t(32) 5 22.47,
P , .05 (MA 5 117, SD 5 60.7, MB 5 162, SD 5 35.7).
To assess differences between PwD and CG ratings, paired
samples t tests revealed only one significant result at T1
for sequence AB, where the ratings of PwDs were lower
than those of CGs: t(6) 5 24.77, P , .01. Paired samples
t tests to test changes in usability scores over time revealed
that neither the usability ratings of PwDs and CGs nor of
dyads with either product differed after each study period.
Results concerning product function and design feature
ratings are presented in Table 4 and Fig. 1. Independent sam-
ples t tests revealed a significant difference in dyads’ rating
of the telephone function at T2.1 between products, where
t(32) 5 22.63, P , .05 (MA 5 2.1, SD 5 1.0, MB 5 3.0,
SD 5 0.8). For overall design features, dyads rated productA worse than B at T3, where t(32) 5 23.18, P , .01
(MA 5 13.7, SD 5 4.3, MB 5 18.4, SD 5 4.4) and CGs at
T2.1, where t(15) 5 22.28, P , .05, similar to PwDs at
T3, where t(15) 5 22.56, P , .05. Concerning individual
design features, dyads rated the font and buttons of product
A worse than those of B at T2.1, t(32) 5 22.24, P , .05
(MA 5 2.4, SD 5 0.7, MB 5 3.1, SD 5 0.9) and
t(32) 5 24.03, P , .001 (MA 5 1.9, SD 5 1.2, MB 5 3.3,
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P, .01 (MA5 2.6, SD5 1.0,MB5 3.6, SD5 0.7), buttons,
t(32) 5 22.67, P , .05 (MA 5 2.2, SD 5 1.5, MB 5 3.4,
SD 5 0.8), and battery life, t(32) 5 23.12, P , .01
(MA 5 1.1, SD 5 1.1, MB 5 2.4, SD 5 1.3) of product A
were rated worse than those of B by dyads. Independent
samples t tests for CGs at T2.1 revealed significant differ-
ences in the ratings of font, t(15)522.70, P, .05 and but-
tons, t(15) 5 23.76, P , .01, and at T3 for buttons,
t(15)523.03, P, .01, all in favor of product B. Likewise,
ratings of PwDs at T2.1 were significantly different for but-
tons, t(15) 5 22.38, P , .05, and at T3 for font,
t(15) 5 22.71, P , .05, size, t(15) 5 22.41, P , .05, and
battery life, t(15) 5 22.73, P , .05. Furthermore, paired
samples t tests showed that the overall design features of
product A were rated worse by CGs than by PwDs at T2.1,
where t(6) 5 2.44, P 5 .05. For individual design features,
PwDs rated the buttons of product A better than CGs at
T2.1, t(6) 5 2.71, P , .05 and at T3, t(9) 5 2.70, P , .05.
To test potential order effects based on receiving product
A or B first, independent samples t tests were performed
and yielded nonsignificant differences in primary outcome
measures.
Finally, results of paired samples t tests for product satis-
faction ratings at the clinic versus home revealed several sig-
nificant differences, with consistently higher ratings at the
clinic. Specifically, a significant difference was found for
product A at T3, where t(19) 5 25.08, P , .001
(Mclinic 5 2.2, SD 5 1.0, Mhome 5 1.1, SD 5 0.9) and for
product B at T2.1, t(19) 5 22.90, P , .01 (Mclinic 5 2.8,Table 4
Product function and design feature ratings over the course of the study
Variables
T2.1
A (n 5 7 dyads) B (n 5 10 dyads)
PwDs CGs PwDs CGs
Product functions
Telephone* 2.1 6 0.9 2.1 6 1.1 3.0 6 0.8 2.9
Location — 2.9 6 0.9 — 2.7
Design features
Overally,z,x 16.3 6 4.2{ 12.0 6 4.3{ 17.2 6 4.2 16.4
Color 3.0 6 0.8 2.4 6 1.3 2.8 6 0.9 2.9
Font*,y,z,x 2.7 6 0.5 2.1 6 0.7 3.0 6 1.1 3.1
Sizex 3.0 6 1.2 2.3 6 0.8 2.4 6 1.2 2.5
Weight 2.9 6 0.7 2.4 6 1.0 3.3 6 0.8 2.9
Buttons*,y,z,#,** 2.6 6 0.5yy 1.1 6 1.2yy 3.3 6 0.7 3.2
Battery lifey,x 2.1 6 1.2 1.6 6 1.5 2.4 6 1.1 1.8
Abbreviations: CGs, caregivers; PwDs, persons with dementia; SD, standard de
NOTE. Continuous variables are displayed as mean value 6 SD (range 0–5); o
*Independent samples t tests for dyads: B rated better than A at T2.1.
yIndependent samples t tests for dyads: B rated better than A at T3.
zIndependent samples t tests for PwDs and CGs: B rated better than A by CGs
xIndependent samples t tests for PwDs and CGs: B rated better than A by PwD
{Paired samples t tests for within-dyad effects: A rated better by PwDs than CG
#Independent samples t tests for PwDs and CGs: B rated better than A by CGs
**Independent samples t tests for PwDs and CGs: B rated better than A by Pw
yyPaired samples t tests for within-dyad effects: A rated better by PwDs than CSD 5 0.8, Mhome 5 2.1, SD 5 1.0) and at T3,
t(13) 5 23.31, P , .01 (Mclinic 5 2.3, SD 5 1.4,
Mhome 5 1.1, SD 5 1.0).3.3. Secondary outcome measures and covariates
Secondary outcome measures and covariates obtained
over the course of the study are presented in Table 5. At base-
line, Spearman’s rank-order correlations revealed that qual-
ity of life and subjective burden of getting lost significantly
correlated (rs 5 0.40, P , .05), and that the latter signifi-
cantly correlated with orientation impairments (rs 5 0.73,
P , .001) and age (rs 5 20.36, P , .05). Furthermore,
paired samples t tests for secondary outcome measures
were performed to test any within-dyad effects between
PwDs and CGs. Significant results were found for orienta-
tion impairments at T1, t(16) 5 4.01, P , .001, T2.1,
t(16) 5 3.85, P , .001, and T3, t(16) 5 2.31, P , .05, as
well as for subjective burden of getting lost at T1,
t(16) 5 12.26, P , .001, T2.1, t(16) 5 4.82, P , .001, and
T3, t(16) 5 5.13, P , .001. A significant difference was
also found for the European Health Interview Surveys-
quality of life at T1, t(16) 5 22.21, P , .001. In all cases,
PwDs rated themselves significantly better than CGs.
Examination of clinical effectiveness with one-way
repeated measures analysis of variances revealed no signifi-
cant changes over the study duration. For the covariate
TA-EG, a significant main effect of time for PwDs, F (2,
32) 5 16.03, P , .001 and for CGs, F (1.11,
17.73) 5 23.64, P , .001 was found, where scores at T1T3
A (n 5 10 dyads) B (n 5 7 dyads)
PwDs CGs PwDs CGs
6 0.9 2.1 6 1.0 2.7 6 1.1 2.7 6 1.1 2.9 6 1.2
6 1.2 — 2.7 6 0.8 — 2.9 6 0.7
6 3.6 14.4 6 3.7 12.9 6 4.8 19.4 6 4.4 17.4 6 4.5
6 0.9 2.6 6 1.0 2.9 6 0.7 3.0 6 0.8 3.0 6 0.8
6 0.7 2.8 6 0.8 2.4 6 1.2 3.7 6 0.5 3.4 6 0.8
6 0.7 2.5 6 1.1 2.3 6 1.1 3.6 6 0.5 2.4 6 1.3
6 1.0 2.6 6 1.2 2.8 6 1.1 3.3 6 1.1 3.0 6 0.8
6 1.0 2.7 6 1.3yy 1.6 6 1.7yy 3.1 6 1.1 3.6 6 0.5
6 1.1 1.2 6 1.1 0.9 6 1.1 2.7 6 1.1 2.0 6 1.5
viation.
verall stands for mean of all design features (range 0–24).
at T2.1 (P value ,.01 for buttons. All other P values ,.05).
s at T3.
s.
at T3.
Ds at T2.1.
Gs.
color
font
size
weight
bu ons 
PwDs, product A
PwDs, product B
CGs, product A
CGs, product B
color
font
size
weight
bu ons 
PwDs, product A
PwDs, product B
CGs, product A
CGs, product B
Fig. 1. Radar charts for design feature ratings at T2.1 (top) and T3 (bottom).
Product A rated by seven dyads at T2.1 and by 10 dyads at T3, and vice-versa
for product B. Abbreviations: CGs, caregivers; PwDs, persons with dementia.
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sults of CGs’ subjective frequency of use of the location func-
tion of product A or B showed that CGs used it a moderateTable 5
Secondary outcome measures and covariates over the course of the study, PwDs (
Variables T1
ZBI (0–48), CGs 14.5 6 6.4 [3–25]
EUROHIS-QOL (0–48)
PwDs 10.2 6 6.6 [1–27]y
CGs 14.7 6 5.7 [6–23]y
TA-EG (19–95)*
PwDs 71.2 6 7.3 [58–85]
CGs 74.1 6 6.1 [63–83]
Orientation impairments (0–5)
PwDs 1.4 6 1.3 [0–5]y
CGs 3.0 6 1.1 [1–4]y
Subjective burden of getting lost (0–5)
PwDs 0.5 6 0.8 [0–3]y
CGs 3.6 6 1.0 [1–5]y
Abbreviations: CGs, caregivers; EUROHIS-QOL, European Health Interview Su
TA-EG, technological affinity scale for electronic products; ZBI, Zarit Burden In
NOTE. Continuous variables are displayed as mean value 6 SD, with minimum
*One-way repeated measures analysis of variances: PwDs and CGs ratings at T
yPaired samples t tests for within-dyad effects: CGs ratings higher than PwDs (amount of times at T2.1 (MA 5 3.0, SD 5 1.4, MB 5 2.6,
SD5 1.1) andT3 (MA5 2.4, SD5 0.8,MB5 2.6, SD5 1.6).
Over the course of the study, product Awas able to assist in
locating PwD in threewandering events (i.e., lost during shop-
ping outing, lost during hiking, and lost during walk out of
home). In two cases, the telephone function assisted and in
the third case the PwD was located with the location function.
Regarding technical difficulties, nine cases were reported for
each product (i.e., problems with the charging cable or dock,
the software, and the telephone function). Of these 18 cases,
CGs reported more difficulties than PwDs (i.e., CGs: n 5 7
for A, n5 6 for B; PwDs: n5 2 for A, n5 3 for B).4. Discussion
The present study reports on the UX with and the clinical
effectiveness resulting from the use of two similar commer-
cial GPS watches used for a period of 4 weeks each in home
dementia care. Although the selected products were similar,
usability ratings by dyads of product B were significantly
better than ratings of product A throughout the study. Differ-
ences in ratings of usability and design features within dyads
are in line with previous studies, which have suggested that
the needs and preferences of PwDs and CGs with GPS de-
vices need to be taken into consideration as they may differ
[7,8,42,43]. Also, the finding that usability ratings with both
products decreased after 4 weeks of use, but not
significantly, seems to imply that users’ expectations could
not be fully met, but that they were not entirely
dissatisfied. The finding that end users’ subjective
technological affinity significantly decreased at the end of
the study may be indirectly associated with decreased
usability ratings. Indeed, it is possible that dissatisfaction
with either product left users to rate themselves as being
less technologically savvy. Furthermore, technical
difficulties may have also contributed to the decrease inn 5 17) and CGs (n 5 17)
T2.1 T3
16.3 6 9.2 [2–41] 17.2 6 8.5 [5–36]
11.9 6 9.1 [2–33] 10.3 6 8.5 [0–34]
14.4 6 6.6 [5–26] 14.6 6 6.2 [6–28]
72.2 6 10.0 [46–87] 58.7 6 7 [43–71]
74.7 6 7.0 [58–82] 56.7 6 10.7 [38–75]
1.5 6 0.9 [0–3]y 1.9 6 1.1 [0–5]y
3.1 6 1.5 [0–5]y 2.7 6 1.5 [0–5]y
1.1 6 1.5 [0–5]y 1.1 6 1.4 [0–4]y
3.4 6 1.2 [1–5]y 3.5 6 1.2 [1–5]y
rveys-quality of life; PwDs, persons with dementia; SD, standard deviation;
terview.
and maximum scores in brackets.
1 and T2.1 higher than at T3, P value ,.001.
P value ,.05 for orientation impairments at T3. All other P values ,.001).
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cited as factors for low product acceptance and use [15,44].
Regarding product functions, we expected CG to prefer
the location function of product B since the last visited posi-
tions of PwD could be viewed. However, it is possible that
users viewed this extra information as nice-to-have, but not
essential or too infringing on their personal privacy. Ethical
considerations regarding privacy constraints, data protec-
tion, autonomy, and personal dignity need to be taken into ac-
count when it comes to product development and use [45,46].
The finding that dyads preferred product B’s telephone
function could be associated with end users’ more
favorable ratings of the buttons of product B. On the other
hand, at all assessments, PwDs preferred the buttons of
product A compared with CGs. This may speak to the need
to design discrete wearable devices to avoid stigmatization
of PwDs [42,47]. Dyads’ better ratings of product B’s font
might be best explained by the concept of “less is more.”
It is important to note that product functions and design
features were assessed with non-standardized self-developed
Likert scales. Currently, no standardized measures exist to
assess these variables, except for parts of the QUEST 2.0
questionnaire [48]. However, this scale focuses on satisfaction
with assistive technologies. Also, the use of the ISONORM
9241/10 scale with PwDs is debatable, as the psychometric
properties of this scale have not been evaluated with PwDs.
Encouragingly, we did not find any order effects. Thus,
receiving product A or B first did not significantly influence
ratings of the second product received. The comparison of
product satisfaction at home versus the clinic showed that
users may bias their answers in clinical settings to avoid ap-
pearing too critical [30]. Note, however, that only one ques-
tion assessed product satisfaction, and dyads jointly rated
this variable. Future studies may benefit from the implemen-
tation of standardized home assessments with digital or
paper-based user diaries [39].
Clinical effectiveness was not found. The short study
duration and the small sample size might explain
this finding. Nevertheless, this assessment is an overarching
goal in research on assistive technologies, with too little
information currently available [19,21]. In practice,
no established guidelines on GPS devices exist,
which makes it difficult for end users to select and for
clinicians to recommend any GPS technology. Nonetheless,
recommendations that support the decision-making process
for professionals in an ethically responsible manner [45]
and that define who will more likely benefit from such tech-
nologies [47] exist. Also, the results on differences between
PwD and CG ratings of orientation impairments and burden
of getting lost could be associated with anosognosia in PwDs
and needs to be addressed sensitively.
A central limitation is the small sample size and the two
dropouts after 4 weeks. It should be noted that most studies
on intelligent assistive technologies have a sample size of
less than 20 participants [13]. Nonetheless, the two dropouts,
as well as the reported technical difficulties and the decreasein participants’ technological affinity suggest that low prod-
uct satisfaction and adoption are real concerns and may add
an additional burden on end users. Also, the selected prod-
ucts were not specifically designed for PwDs and CGs, but
rather for a heterogeneous population, which is typical for
most commercial GPS devices. Proactive ways to address
these issues include designing products that are adaptive to
the changing needs of specific end users and that are tested
in large, randomized controlled studies that follow a user-
centered design [8,20,43]. We also did not focus on the
cost of either product, although this has been found to
influence product acceptability [49]. Furthermore, history
of wandering behavior, which frequently occurs in later dis-
ease stages [50], but that can happen at any disease stage
[51], was not an inclusion criterion. Indeed, most CGs re-
ported PwDs as having a history of wandering behavior.
Another limitation was the lack of objective data on users’
frequency of use. Finally, the crossover design did not
include a washout period to avoid having carryover effects
(e.g., learning effects) confound outcome measures. Howev-
er, no order effects were detected, which indicates that po-
tential learning effects did not influence UX.
Study strengths include the dyadic design, pre-assessments
and post-assessments, and the development and implementa-
tion of a technological training session. Furthermore, the
assessment of the telephone function was deemed important
as devices featuring this function are less passive, making
them likely better suited for PwDs in earlier disease stages.
Two of three PwDs who wandered were located by using
the telephone function. Also, self-developed Likert scales
were visualized to make them easier to understand. Overall,
the detailed UX findings highlight the need to perform in-
depth and dyadic analyses.
In conclusion, the results presented here support specific
design recommendations for GPSwatches in home dementia
care. Specifically, devices should contain few buttons,
display a clear font with parsimonious text, and have a bat-
tery life of at least 24 hours. Indeed, “for any kind of product
or service, it’s the little things that count” [52]. In spite of the
mentioned limitations, this study provides a starting point
for research on UX and clinical effectiveness with wearable
GPS devices. Future studies using a randomized mixed-
method dyadic approach with standardized and validated
outcome measures are needed [43,53].Acknowledgments
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1. Systematic review: The authors reviewed all relevant
publications on the user experience and clinical
effectiveness with wearable global positioning sys-
tem (GPS) devices for persons with dementia
(PwDs) and caregivers (CGs) using PubMed,
meeting abstracts, and presentations. This is the first
user experience study comparing two commercial
GPS watches in home dementia care with data
from PwDs and CGs, and reporting on clinical effec-
tiveness resulting from product use.
2. Interpretation: Our results support specific design
recommendations for GPS watches in home demen-
tia care. Namely, devices should contain few buttons,
display a clear font with limited text, and have a bat-
tery life of at least 24 hours. Addressing these recom-
mendations may contribute to measurable clinical
effectiveness.
3. Future directions: Given the number of commercially
available GPS watches and their low use in home de-
mentia care, our results highlight the importance of
optimizing products. Future studies with a random-
ized mixed-method dyadic approach and with stan-
dardized and validated outcome measures are
warranted.References
[1] Van der Roest HG, Wenborn J, Pastink C, Dr€oes RM, Orrell M. Assis-
tive technology for memory support in dementia. Cochrane Database
Syst Rev 2017;6:1–27.
[2] Samus QM, Lyketsos CG, Black BS, Bovenkamp D, Buckley M,
Callahan C, et al. Home is where the future is: The BrightFocus Foun-dation consensus panel on dementia care. Alzheimers Dement 2017;
14:104–14.
[3] McShane R, Gedling K, Kenward B, Kenward R, Hope T, Jacoby R.
The feasibility of electronic tracking devices in dementia: a telephone
survey and case series. Int J Geriatr Psychiatry 1998;13:556–63.
[4] Miskelly F. A novel system of electronic tagging in patients with de-
mentia and wandering. Age Ageing 2004;33:304–6.
[5] Oderud T, Landmark B, Eriksen S, Fossberg AB, Aketun S,
Omland M, et al. Persons with dementia and their caregivers using
GPS. Stud Health Technol Inform 2015;217:212–21.
[6] Pot AM, Willemse BM, Horjus S. A pilot study on the use of tracking
technology: feasibility, acceptability, and benefits for people in early
stages of dementia and their informal caregivers. Aging Ment Health
2012;16:127–34.
[7] Robinson L, Brittain K, Lindsay S, Jackson D, Olivier P. Keeping in
touch everyday (KITE) project: developing assistive technologies
with people with dementia and their carers to promote independence.
Int Psychogeriatr 2009;21:494–502.
[8] Megges H, Freiesleben SD, Jankowski N, Haas B, Peters O. Technol-
ogy for home dementia care: A prototype locating system put to the
test. Alzheimers Dement 2017;3:332–8.
[9] Olsson A, Engstr€om M, Asenl€of P, Skovdahl K, Lampic C. Effects of
tracking technology on daily life of persons with dementia: Three
experimental single-case studies. Am J Alzheimers Dis Other Demen
2014;30:29–40.
[10] Wan L, M€uller C, Wulf V, Randall D. Addressing the subtleties in de-
mentia care: pre-study & evaluation of a GPS monitoring system, Pro-
ceedings of the SIGCHI conference on human factors in computing
systems. Toronto: ACM; 2014. p. 3987–96.
[11] Williamson B, Aplin T, de Jonge D, Goyne M. Tracking down a solu-
tion: exploring the acceptability and value of wearable GPS devices for
older persons, individuals with a disability and their support persons.
Disabil Rehabil Assist Technol 2017;12:822–31.
[12] Asghar I, Cang S, Yu H. Usability evaluation of assistive technologies
through qualitative research focusing on people with mild dementia.
Comput Hum Behav 2018;79:192–201.
[13] Ienca M, Fabrice J, Elger B, Caon M, Pappagallo AS, Kressig RW,
et al. Intelligent assistive technology for Alzheimer’s disease and
other dementias: A systematic review. J Alzheimers Dis 2017;
56:1301–40.
[14] Neubauer NA, Lapierre N, Rıos-Rincon A, Miguel-Cruz A,
Rousseau J, Liu L. What do we know about technologies for
dementia-related wandering? A scoping review: Examen de la portee:
que savons-nous a propos des technologies de gestion de l’errance liee
a la demence? Can J Occup Ther 2018;85:196–208.
[15] Bantry White E, Montgomery P, McShane R. Electronic tracking for
people with dementia who get lost outside the home: a study of the
experience of familial carers. Br J Occup Ther 2010;73:152–9.
[16] Sauer A. 10 Lifesaving Location Devices for Dementia Patients US:
alzheimers.net, 2018. Available at: https://www.alzheimers.net/
8-8-14-location-devices-dementia/. Accessed September 14, 2018.
[17] Dale Ø. Usability and usefulness of GPS based localization technology
used in dementia care. In: International conference on computers for
handicapped persons. Vienna: Springer; 2010. p. 300–7.
[18] Liu L, Miguel Cruz A, Ruptash T, Barnard S, Juzwishin D.
Acceptance of global positioning system (GPS) technology among de-
mentia clients and family caregivers. J Technol Hum Serv 2017;
35:99–119.
[19] Meiland F, Innes A,Mountain G, Robinson L, van der Roest H, Garcıa-
Casal JA, et al. Technologies to support community-dwelling persons
with dementia: a position paper on issues regarding development, us-
ability, effectiveness and cost-effectiveness, deployment, and ethics.
JMIR Rehabil Assist Technol 2017;4:1–21.
[20] Topfer LA. GPS locator devices for people with dementia. CADTH is-
sues in emerging health technologies. Ottawa: Canadian Agency for
Drugs and Technologies in Health; 2016. p. 1–14.
H. Megges et al. / Alzheimer’s & Dementia: Translational Research & Clinical Interventions 4 (2018) 636-644644[21] Livingston G, Sommerlad A, Orgeta V, Costafreda SG, Huntley J,
Ames D, et al. Dementia prevention, intervention, and care. Lancet
2017;390:1–62.
[22] Brims L, Oliver K. Effectiveness of assistive technology in improving
the safety of people with dementia: a systematic review andmeta-anal-
ysis. Aging Ment Health 2018:1–10.
[23] ISO9241-210. Ergonomics of human-system interaction—Part 210:
human-centred design for interactive systems. Geneva, CH: Interna-
tional Organization for Standardization ISO; 2010.
[24] Forlizzi J, Ford S. The building blocks of experience: an early frame-
work for interaction designers. In: Proceedings of the 3rd conference
on designing interactive systems: processes, practices, methods, and
techniques. New York: ACM; 2000. p. 419–23.
[25] Law E, Roto V, Vermeeren APOS, Kort J, Hassenzahl M. Towards a
shared definition of user experience. Extended abstracts on human fac-
tors in computing systems. Florence: ACM; 2008. p. 2395–8.
[26] Davis FD, Bagozzi RP, Warshaw PR. User acceptance of computer
technology: a comparison of two theoretical models. Manage Sci
1989;35:982–1003.
[27] Hornbæk K, HertzumM. Technology acceptance and user experience:
A review of the experiential component in HCI. ACM Trans Comput-
Hum Interact 2017;24:33.
[28] Hassenzahl M. The thing and I: Understanding the relationship be-
tween user and product. In: Mark A, Blythe AFM, Overbeeke K,
Wright PC, eds. Funology: FromUsability to Enjoyment. Netherlands:
Kluwer Academic Publishers; 2003. p. 31–42.
[29] Natesan D,WalkerM, Clark S. Cognitive bias in usability testing. Proc
Int Symp Hum Factors Ergon Healthc 2016;5:86–8.
[30] Edwards AL. The social desirability variable in personality assessment
and research. Acad Med 1958;33:610–1.
[31] Haberstroh J, Pantel J. Kommunikation bei Demenz: TANDEMTrain-
ings manual. [Communication in dementia: TANDEM training
manual]. Heidelberg: Springer; 2011.
[32] Feil N, de Klerk-Rubin V. The Validation Breakthrough: Simple Tech-
niques for Communicating With People With Alzheimer’s and Other
Dementias. 3 ed. Baltimore: Health Professions Press; 2012.
[33] Bedard M, Molloy DW, Squire L, Dubois S, Lever JA, O’Donnell M.
The Zarit Burden Interview: A new short version and screening
version. Gerontologist 2001;41:652–7.
[34] Br€ahler E, M€uhlan H, Albani C, Schmidt S. Teststatistische Pr€ufung
und Normierung der deutschen Versionen des EUROHIS-QOL Leb-
ensqualit€at-Index und des WHO-5 Wohlbefindens-Index [Statistical
testing and standardization of the German version of the EUROHIS-
QOL quality of life index and theWHO-5 well-being index]. Diagnos-
tica 2007;53:83–96.
[35] Karrer K, Glaser C, Clemens C, Bruder C. Technikaffinit€at erfassen–
der Fragebogen TA-EG [Assessment of technological affinity-the
TA-EG]. Mensch Mittelpunkt Technischer Systeme 2009;
8:196–201.
[36] Pr€umper J. Der Benutzungsfragebogen ISONORM 9241/10: Ergeb-
nisse zur Reliabilit€at und Validit€at [The Usability Questionnaire ISO
(International Organization for Standardization) NORM 9241/10: re-
sults on reliability and validity]. In: Liskowsky R, Velichkovsky B,W€unschmann W, eds. Software-Ergonomie ’97. Wiesbaden: View-
eg1Teubner Verlag; 1997. p. 253–62.
[37] Pr€umper J. Software-evaluation based upon ISO 9241 Part 10. Berlin,
Heidelberg: Springer; 1993. p. 255–65.
[38] ISO9241-110. Ergonomics of human-system interaction—Part 110:
dialogue principles [Revision of ISO 9241-10:1996 Ergonomic re-
quirements for office work with visual display terminals (VDTs)—
Part 10: dialogue principles]. Geneva, CH: International Standard Or-
ganization ISO; 2006.
[39] Sarodnick F, Brau H. Methoden der Usability Evaluation: Wissen-
schaftliche Grundlagen und praktische Anwendung [Methods of us-
ability assessment: scientific foundations and practical application].
1 ed. Bern: Huber; 2006.
[40] Kenny DA, Kashy DA, Cook WL. The analysis of dyadic data. New
York: Guilford Press; 2006.
[41] Field A. Discovering statistics using SPSS. 3 ed. London: Sage; 2009.
[42] Wood E,Ward G, Woolham J. The development of safer walking tech-
nology: a review. J Assist Technol 2015;9:100–15.
[43] MacAndrew M, Brooks D, Beattie E. Nonpharmacological interven-
tions for managing wandering in the community: A narrative review
of the evidence base. Health Soc Care Community 2018:1–14.
https://doi.org/10.1111/hsc.12590.
[44] Olsson A, Engstr€om M, Lampic C, Skovdahl K. A passive positioning
alarm used by persons with dementia and their spouses—a qualitative
intervention study. BMC Geriatr 2013;13:11.
[45] Bantry-White E. Supporting ethical use of electronic monitoring
for people living with dementia: social work’s role in assessment,
decision-making, and review. J Gerontol Soc Work 2018;
61:261–79.
[46] Robillard JM, Cleland I, Hoey J, Nugent C. Ethical adoption: A new
imperative in the development of technology for dementia. Alzheimers
Dement 2018;14:1104–13.
[47] Chen Y-C, Leung C-Y. Exploring functions of the lost seeking devices
for people with dementia. Work 2012;41:3093–100.
[48] Demers L, Weiss-Lambrou R, Ska B. The Quebec user evaluation of
satisfaction with assistive technology (QUEST 2.0): an overview
and recent progress. Technol Disabil 2002;14:101–5.
[49] Peek STM, Wouters EJM, van Hoof J, Luijkx KG, Boeije HR,
Vrijhoef HJM. Factors influencing acceptance of technology for
aging in place: A systematic review. Int J Med Inf 2014;
83:235–48.
[50] Lai CKY, Arthur DG.Wandering behaviour in people with dementia. J
Adv Nurs 2003;44:173–82.
[51] Association As. Behaviors: How to Respond When Dementia Causes
Unpredictable Behaviors. Chicago: Alzheimer’s Association; 2015. p.
1–13.
[52] Garrett JJ. The elements of User Experience: User-Centered
Design for the Web and Beyond. 2 ed. Berkeley: Pearson Education;
2010.
[53] Patomella A-H, Lovarini M, Lindqvist E, Kottorp A, Nygard L. Tech-
nology use to improve everyday occupations in older persons with
mild dementia or mild cognitive impairment: A scoping review. Br J
Occup Ther 2018;0. 0308022618771533.
